{"transactions":[{"id":1157081,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-06T17:58:08.000Z","date":"2025-05-05","kind":"purchase","planned":false,"acquired":true,"shares":34000,"price":8.805,"value":299370.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.765 to $8.850, inclusive. The reporting person undertakes to provide to Organon & Co. (\"Organon\"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":282731.157,"source":{"system":"sec-edgar","filing":"0001821825-25-000025","document":"wk-form4_1746554281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182525000025/wk-form4_1746554281.xml","form_type":"4"}},{"id":1182325,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":21472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21472},"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182324,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":38974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026."}],"balance_after":38974,"derivative":{"underlying":"Common Stock","underlying_shares":38974},"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182323,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":48758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."}],"balance_after":97518,"derivative":{"underlying":"Common Stock","underlying_shares":48758},"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182322,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":218267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":218267,"derivative":{"underlying":"Common Stock","underlying_shares":218267},"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182321,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":1072607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":1072607,"derivative":{"exercise_price":14.89,"underlying":"Common Stock","underlying_shares":1072607},"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182320,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":11875,"price":14.51,"value":172306.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":248731.157,"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182319,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":21472,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":260606.157,"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182318,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":21553,"price":14.51,"value":312734.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":239134.157,"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182317,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":38974,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":260687.157,"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182316,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":26964,"price":14.51,"value":391247.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":221713.157,"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1182315,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-02T21:32:00.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":48758,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":248677.157,"source":{"system":"sec-edgar","filing":"0001859698-25-000006","document":"wk-form4_1743629513.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000006/wk-form4_1743629513.xml","form_type":"4"}},{"id":1248761,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-24T21:59:32.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":8529,"price":15.29,"value":130408.41,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the addition of 10,490.157 shares of Common Stock acquired from dividend reinvestments not previously reported."}],"balance_after":199919.157,"source":{"system":"sec-edgar","filing":"0001859698-25-000004","document":"wk-form4_1740434367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000004/wk-form4_1740434367.xml","form_type":"4"}},{"id":1248760,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-24T21:59:32.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":15423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above."}],"balance_after":197958,"source":{"system":"sec-edgar","filing":"0001859698-25-000004","document":"wk-form4_1740434367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000004/wk-form4_1740434367.xml","form_type":"4"}},{"id":1248759,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-24T21:59:32.000Z","date":"2025-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":46575,"price":14.92,"value":694899.0,"ownership":{"direct":true},"balance_after":182535,"source":{"system":"sec-edgar","filing":"0001859698-25-000004","document":"wk-form4_1740434367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000004/wk-form4_1740434367.xml","form_type":"4"}},{"id":1248758,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-24T21:59:32.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":84222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Organon & Co. common stock (\"Common Stock\") for performance share units (\"PSUs\") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors."}],"balance_after":229110,"source":{"system":"sec-edgar","filing":"0001859698-25-000004","document":"wk-form4_1740434367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000185969825000004/wk-form4_1740434367.xml","form_type":"4"}},{"id":1413429,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:32:00.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11927,"price":20.35,"value":242714.45,"ownership":{"direct":true},"balance_after":144888,"source":{"system":"sec-edgar","filing":"0001821825-24-000102","document":"wk-form4_1725568313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000102/wk-form4_1725568313.xml","form_type":"4"}},{"id":1413428,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-05T20:32:00.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":21567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Organon & Co. common stock for performance share units granted to the reporting person on August 17, 2021 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors."}],"balance_after":156815,"source":{"system":"sec-edgar","filing":"0001821825-24-000102","document":"wk-form4_1725568313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000102/wk-form4_1725568313.xml","form_type":"4"}},{"id":1524249,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-07T20:06:27.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":22161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22161},"source":{"system":"sec-edgar","filing":"0001821825-24-000062","document":"wk-form4_1715112373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000062/wk-form4_1715112373.xml","form_type":"4"}},{"id":1524248,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-07T20:06:27.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":12256,"price":19.61,"value":240340.16,"ownership":{"direct":true},"balance_after":135248,"source":{"system":"sec-edgar","filing":"0001821825-24-000062","document":"wk-form4_1715112373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000062/wk-form4_1715112373.xml","form_type":"4"}},{"id":1524247,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-07T20:06:27.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":22161,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":147504,"source":{"system":"sec-edgar","filing":"0001821825-24-000062","document":"wk-form4_1715112373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000062/wk-form4_1715112373.xml","form_type":"4"}},{"id":1548358,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-03T22:41:21.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":false,"shares":38973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026."}],"balance_after":77948,"derivative":{"underlying":"Common Stock","underlying_shares":38973},"source":{"system":"sec-edgar","filing":"0001821825-24-000046","document":"wk-form4_1712184071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000046/wk-form4_1712184071.xml","form_type":"4"}},{"id":1548357,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-03T22:41:21.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":false,"shares":21471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025."}],"balance_after":21472,"derivative":{"underlying":"Common Stock","underlying_shares":21471},"source":{"system":"sec-edgar","filing":"0001821825-24-000046","document":"wk-form4_1712184071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000046/wk-form4_1712184071.xml","form_type":"4"}},{"id":1548356,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:41:21.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":21553,"price":18.8,"value":405196.4,"ownership":{"direct":true},"balance_after":125343,"source":{"system":"sec-edgar","filing":"0001821825-24-000046","document":"wk-form4_1712184071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000046/wk-form4_1712184071.xml","form_type":"4"}},{"id":1548355,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:41:21.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":true,"shares":38973,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":146896,"source":{"system":"sec-edgar","filing":"0001821825-24-000046","document":"wk-form4_1712184071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000046/wk-form4_1712184071.xml","form_type":"4"}},{"id":1548354,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:41:21.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":11874,"price":18.8,"value":223231.2,"ownership":{"direct":true},"balance_after":107923,"source":{"system":"sec-edgar","filing":"0001821825-24-000046","document":"wk-form4_1712184071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000046/wk-form4_1712184071.xml","form_type":"4"}},{"id":1548353,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-04-03T22:41:21.000Z","date":"2024-03-31","kind":"exercise","planned":false,"acquired":true,"shares":21471,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":119797,"source":{"system":"sec-edgar","filing":"0001821825-24-000046","document":"wk-form4_1712184071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000046/wk-form4_1712184071.xml","form_type":"4"}},{"id":1552520,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-02T20:29:36.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":599128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":599128,"derivative":{"exercise_price":18.8,"exercise_date":"2025-03-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":599128},"source":{"system":"sec-edgar","filing":"0001821825-24-000033","document":"wk-form4_1712089757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000033/wk-form4_1712089757.xml","form_type":"4"}},{"id":1552519,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T20:29:36.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":146276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":146276,"derivative":{"exercise_date":"2025-03-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":146276},"source":{"system":"sec-edgar","filing":"0001821825-24-000033","document":"wk-form4_1712089757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000033/wk-form4_1712089757.xml","form_type":"4"}},{"id":1605782,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-01T21:23:29.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":88121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":88121},"source":{"system":"sec-edgar","filing":"0001821825-24-000009","document":"wk-form4_1709328202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000009/wk-form4_1709328202.xml","form_type":"4"}},{"id":1605781,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-01T21:23:29.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":40414,"price":18.04,"value":729068.56,"ownership":{"direct":true},"balance_after":98326,"source":{"system":"sec-edgar","filing":"0001821825-24-000009","document":"wk-form4_1709328202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000009/wk-form4_1709328202.xml","form_type":"4"}},{"id":1605780,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-01T21:23:29.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":88121,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."}],"balance_after":138740,"source":{"system":"sec-edgar","filing":"0001821825-24-000009","document":"wk-form4_1709328202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000182182524000009/wk-form4_1709328202.xml","form_type":"4"}},{"id":1900578,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-08T22:42:00.000Z","date":"2023-05-04","kind":"exercise","planned":false,"acquired":false,"shares":22158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."}],"balance_after":22161,"derivative":{"exercise_date":"2023-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":22158},"source":{"system":"sec-edgar","filing":"0001209191-23-028095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123028095/doc4.xml","form_type":"4"}},{"id":1900577,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-08T22:42:00.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":12254,"price":24.24,"value":297036.96,"ownership":{"direct":true},"balance_after":50619,"source":{"system":"sec-edgar","filing":"0001209191-23-028095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123028095/doc4.xml","form_type":"4"}},{"id":1900576,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-08T22:42:00.000Z","date":"2023-05-04","kind":"exercise","planned":false,"acquired":true,"shares":22158,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On each of May 4, 2022 and May 4, 2023, one-third of the RSUs vested, with the remaining RSUs to vest on May 4, 2024."}],"balance_after":62873,"source":{"system":"sec-edgar","filing":"0001209191-23-028095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123028095/doc4.xml","form_type":"4"}},{"id":1905425,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-03T23:05:15.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":2711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."}],"balance_after":0,"derivative":{"exercise_date":"2023-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":2711},"source":{"system":"sec-edgar","filing":"0001209191-23-027170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123027170/doc4.xml","form_type":"4"}},{"id":1905424,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-03T23:05:15.000Z","date":"2023-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1491,"price":24.63,"value":36723.33,"ownership":{"direct":true},"balance_after":40715,"source":{"system":"sec-edgar","filing":"0001209191-23-027170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123027170/doc4.xml","form_type":"4"}},{"id":1905423,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-03T23:05:15.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":2711,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested."}],"balance_after":42206,"source":{"system":"sec-edgar","filing":"0001209191-23-027170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123027170/doc4.xml","form_type":"4"}},{"id":1926434,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-05T00:13:41.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":419847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026."}],"balance_after":419847,"derivative":{"exercise_price":23.52,"exercise_date":"2024-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":419847},"source":{"system":"sec-edgar","filing":"0001209191-23-023073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023073/doc4.xml","form_type":"4"}},{"id":1926433,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:13:41.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":116921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026."}],"balance_after":116921,"derivative":{"exercise_date":"2024-03-31","expiration_date":"2026-03-31","underlying":"Common Stock","underlying_shares":116921},"source":{"system":"sec-edgar","filing":"0001209191-23-023073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023073/doc4.xml","form_type":"4"}},{"id":1926432,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T00:13:41.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":21471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. (\"Organon\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025."}],"balance_after":42943,"derivative":{"underlying":"Common Stock","underlying_shares":21471},"source":{"system":"sec-edgar","filing":"0001209191-23-023073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023073/doc4.xml","form_type":"4"}},{"id":1926431,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:13:41.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":11895,"price":23.09,"value":274655.55,"ownership":{"direct":true},"balance_after":39495,"source":{"system":"sec-edgar","filing":"0001209191-23-023073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023073/doc4.xml","form_type":"4"}},{"id":1926430,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:13:41.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":21471,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51390,"source":{"system":"sec-edgar","filing":"0001209191-23-023073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123023073/doc4.xml","form_type":"4"}},{"id":1978320,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-02T22:20:43.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":11393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023."}],"balance_after":0,"derivative":{"exercise_date":"2022-12-31","expiration_date":"2022-12-31","underlying":"Common Stock","underlying_shares":11393},"source":{"system":"sec-edgar","filing":"0001209191-23-014823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123014823/doc4.xml","form_type":"4"}},{"id":1978319,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-02T22:20:43.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":6387,"price":25.09,"value":160249.83,"ownership":{"direct":true},"balance_after":29919,"source":{"system":"sec-edgar","filing":"0001209191-23-014823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123014823/doc4.xml","form_type":"4"}},{"id":1978318,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-02T22:20:43.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":11393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit converts into one share of Organon & Co. common stock."}],"balance_after":36306,"source":{"system":"sec-edgar","filing":"0001209191-23-014823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000120919123014823/doc4.xml","form_type":"4"}},{"id":2280424,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-06T00:45:34.000Z","date":"2022-05-04","kind":"exercise","acquired":false,"shares":22158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024."}],"balance_after":22158,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":22158},"source":{"system":"sec-edgar","filing":"0001104659-22-056625","document":"tm2214603-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056625/tm2214603-1_4seq1.xml","form_type":"4"}},{"id":2280423,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-06T00:45:34.000Z","date":"2022-05-03","kind":"exercise","acquired":false,"shares":2631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":2631,"derivative":{"exercise_date":"2022-05-03","expiration_date":"2022-05-03","underlying":"Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001104659-22-056625","document":"tm2214603-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056625/tm2214603-1_4seq1.xml","form_type":"4"}},{"id":2280422,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-06T00:45:34.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":12254,"price":32.44,"value":397519.76,"ownership":{"direct":true},"balance_after":24913,"source":{"system":"sec-edgar","filing":"0001104659-22-056625","document":"tm2214603-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056625/tm2214603-1_4seq1.xml","form_type":"4"}},{"id":2280421,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-06T00:45:34.000Z","date":"2022-05-04","kind":"exercise","acquired":true,"shares":22158,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":37167,"source":{"system":"sec-edgar","filing":"0001104659-22-056625","document":"tm2214603-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056625/tm2214603-1_4seq1.xml","form_type":"4"}},{"id":2280420,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-06T00:45:34.000Z","date":"2022-05-03","kind":"tax_withholding","acquired":false,"shares":1270,"price":32.08,"value":40741.6,"ownership":{"direct":true},"balance_after":15009,"source":{"system":"sec-edgar","filing":"0001104659-22-056625","document":"tm2214603-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056625/tm2214603-1_4seq1.xml","form_type":"4"}},{"id":2280419,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-06T00:45:34.000Z","date":"2022-05-03","kind":"exercise","acquired":true,"shares":2631,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."}],"balance_after":16279,"source":{"system":"sec-edgar","filing":"0001104659-22-056625","document":"tm2214603-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922056625/tm2214603-1_4seq1.xml","form_type":"4"}},{"id":2283652,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-03T23:38:13.000Z","date":"2022-05-01","kind":"exercise","acquired":false,"shares":2709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."}],"balance_after":2709,"derivative":{"exercise_date":"2022-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":2709},"source":{"system":"sec-edgar","filing":"0001104659-22-055425","document":"tm2214297-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922055425/tm2214297-1_4seq1.xml","form_type":"4"}},{"id":2283651,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-03T23:38:13.000Z","date":"2022-05-01","kind":"tax_withholding","acquired":false,"shares":1523,"price":32.33,"value":49238.59,"ownership":{"direct":true},"balance_after":13648,"source":{"system":"sec-edgar","filing":"0001104659-22-055425","document":"tm2214297-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922055425/tm2214297-1_4seq1.xml","form_type":"4"}},{"id":2283650,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-03T23:38:13.000Z","date":"2022-05-01","kind":"exercise","acquired":true,"shares":2709,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023."}],"balance_after":15171,"source":{"system":"sec-edgar","filing":"0001104659-22-055425","document":"tm2214297-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922055425/tm2214297-1_4seq1.xml","form_type":"4"}},{"id":2306973,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-04T22:02:31.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":198412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":198412,"derivative":{"exercise_price":34.93,"exercise_date":"2023-03-31","expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":198412},"source":{"system":"sec-edgar","filing":"0001104659-22-042353","document":"tm2211465-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922042353/tm2211465-1_4seq1.xml","form_type":"4"}},{"id":2306972,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T22:02:31.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":64414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Organon & Co. (\"Organon\") common stock for each RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025."}],"balance_after":64414,"derivative":{"exercise_date":"2023-03-31","expiration_date":"2025-03-31","underlying":"Common Stock","underlying_shares":64414},"source":{"system":"sec-edgar","filing":"0001104659-22-042353","document":"tm2211465-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922042353/tm2211465-1_4seq1.xml","form_type":"4"}},{"id":2359175,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-02T23:46:30.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":14529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit converts into one share of Organon & Co. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022."},{"field":"shares","element":"transactionShares","label":"F3","text":"The amount of the Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022."}],"balance_after":0,"derivative":{"exercise_date":"2021-12-31","expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":14529},"source":{"system":"sec-edgar","filing":"0001104659-22-029456","document":"tm228175-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922029456/tm228175-4_4seq1.xml","form_type":"4"}},{"id":2359174,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-02T23:46:30.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":6469,"price":37.57,"value":243040.33,"ownership":{"direct":true},"balance_after":12462,"source":{"system":"sec-edgar","filing":"0001104659-22-029456","document":"tm228175-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922029456/tm228175-4_4seq1.xml","form_type":"4"}},{"id":2359173,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-02T23:46:30.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":14529,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converts into one share of Organon & Co. common stock."}],"balance_after":18931,"source":{"system":"sec-edgar","filing":"0001104659-22-029456","document":"tm228175-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000110465922029456/tm228175-4_4seq1.xml","form_type":"4"}},{"id":2595710,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-19T20:59:07.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":133928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal installments on August 17, 2022, August 17, 2023 and August 17, 2024."}],"balance_after":133928,"derivative":{"exercise_price":35.38,"exercise_date":"2022-08-17","expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":133928},"source":{"system":"sec-edgar","filing":"0000899243-21-033654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321033654/doc4.xml","form_type":"4"}},{"id":2680311,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":515471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vests and becomes exercisable in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":515471,"derivative":{"exercise_price":36.11,"exercise_date":"2022-05-04","expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":515471},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680310,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":63578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"21,191 shares underlying the option are fully vested. The remaining shares vest and become exercisable in two equal installments on May 1, 2022 and May 1, 2023."}],"balance_after":63578,"derivative":{"exercise_price":36.91,"exercise_date":"2022-05-01","expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":63578},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680309,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":59412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"39,608 shares underlying the option are fully vested. The remaining shares vest and become exercisable on May 3, 2022."}],"balance_after":59412,"derivative":{"exercise_price":38.01,"exercise_date":"2022-05-03","expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":59412},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680308,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":77028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":77028,"derivative":{"exercise_price":27.44,"exercise_date":"2021-06-02","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":77028},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680307,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":72063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":72063,"derivative":{"exercise_price":30.4,"exercise_date":"2021-06-02","expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":72063},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680306,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":38120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":38120,"derivative":{"exercise_price":25.98,"exercise_date":"2021-06-02","expiration_date":"2026-05-09","underlying":"Common Stock","underlying_shares":38120},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680305,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":60821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":60821,"derivative":{"exercise_price":28.44,"exercise_date":"2021-06-02","expiration_date":"2025-04-30","underlying":"Common Stock","underlying_shares":60821},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680304,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":27021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the Separation, each outstanding Merck stock option was converted into an award of options to purchase shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of shares and exercise price of each option award was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck stock option. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":27021,"derivative":{"exercise_price":27.67,"exercise_date":"2021-06-02","expiration_date":"2024-05-01","underlying":"Common Stock","underlying_shares":27021},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680303,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":88121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2023."}],"balance_after":88121,"derivative":{"exercise_date":"2023-12-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":88121},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680302,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":11393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These restricted stock units vest and are distributed as shares of Organon common stock in a single installment on December 31, 2022."}],"balance_after":11393,"derivative":{"exercise_date":"2022-12-31","expiration_date":"2022-12-31","underlying":"Common Stock","underlying_shares":11393},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680301,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":14528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Separation, each outstanding Merck performance stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck performance stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":14528,"derivative":{"exercise_date":"2021-12-31","expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":14528},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680300,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":66477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on May 4, 2022, May 4, 2023 and May 4, 2024."}],"balance_after":66477,"derivative":{"exercise_date":"2022-05-04","expiration_date":"2024-05-04","underlying":"Common Stock","underlying_shares":66477},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680299,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":5420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vest and are distributed as shares of Organon common stock in two equal installments on May 1, 2022 and May 1, 2023."}],"balance_after":5420,"derivative":{"exercise_date":"2022-05-01","expiration_date":"2023-05-01","underlying":"Common Stock","underlying_shares":5420},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}},{"id":2680298,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":80090,"kind":"person","name":"Ali Kevin","position":1,"cik":"0001859698","reported_name":"Ali Kevin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-05T01:24:23.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":2631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Organon common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the Separation, each outstanding Merck restricted stock unit award was converted into a restricted stock unit award denominated in shares of Organon common stock pursuant to the terms of the employee matters agreement between Merck and Organon. The number of underlying shares was adjusted in a manner intended to preserve the aggregate intrinsic value of the original Merck restricted stock unit award. The value reflects Organon's best estimate of the numbers using the currently available information and may be subject to adjustment following finalization of calculations."}],"balance_after":2631,"derivative":{"exercise_date":"2022-05-03","expiration_date":"2022-05-03","underlying":"Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0000899243-21-022190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821825/000089924321022190/doc4.xml","form_type":"4"}}]}